Rare diseases
Investigational molecules
Locations
474 conditions with trials, the busiest first
1 133 trials across Europe, recruiting first
Study on Pembrolizumab for Patients with Localized Non-Metastatic MSI/dMMR Tumors or EBV+ Gastric Cancer
FranceStudy on the Safety and Effectiveness of Patritumab Deruxtecan for Patients with Colorectal, Biliary Tract, and Liver Cancer
FranceStudy on Oxaliplatin and Irinotecan for Patients with Metastatic Colorectal Cancer in the Liver
BelgiumStudy on the Effects of Fecal Microbiome and Fecal Microbiome Filtrate Capsules for Patients with Active Ulcerative Colitis
GermanyStudy of Pembrolizumab for Patients with Recurrent, Platinum-Resistant Ovarian, Fallopian Tube, and Primary Peritoneal Cancer
ItalyStudy on Niraparib and Dostarlimab for Patients with HPV-Negative Head and Neck Squamous Cell Carcinoma
ItalyStudy on Napabucasin with FOLFIRI for Adults with Metastatic Colorectal Cancer After Standard Treatments
FranceStudy on the Use of Allogeneic Adipose-Derived Mesenchymal Stem Cells for Treating Ulcerative Colitis in Patients
DenmarkStudy comparing chemotherapy with or without radiation therapy in patients with resectable gastroesophageal junction cancer using docetaxel, oxaliplatin, fluorouracil and calcium folinate
GermanyStudy on Bevacizumab and Drug Combination for Patients with Resectable Colorectal Peritoneal Metastases
BelgiumStudy of Rucaparib and Nivolumab for Maintenance Treatment in Patients with Advanced Ovarian, Fallopian Tube, or Primary Peritoneal Cancer After Chemotherapy
BelgiumStudy on the Long-Term Safety and Effectiveness of Glepaglutide for Patients with Short Bowel Syndrome
BelgiumThe therapies tested most often in Gastrointestinal disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
